Candida guilliermondii/Kodamaea ohmeri Endocarditis
Mycopathologia
.
2023 Dec;188(6):907-908.
doi: 10.1007/s11046-023-00767-5.
Epub 2023 Aug 3.
Authors
Jonathan N Wilcock
1
2
,
Andrew J Gallagher
3
,
Nancy L Wengenack
4
,
Cindy D Noyes
3
,
John C Klick
3
,
Christina M Wojewoda
3
Affiliations
1
The University of Vermont Medical Center, Burlington, VT, USA. wilcock.jonathan@mayo.edu.
2
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55904, USA. wilcock.jonathan@mayo.edu.
3
The University of Vermont Medical Center, Burlington, VT, USA.
4
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55904, USA.
PMID:
37537295
DOI:
10.1007/s11046-023-00767-5
No abstract available
MeSH terms
Antifungal Agents / therapeutic use
Saccharomycetales*
Substances
Antifungal Agents
Supplementary concepts
Kodamaea ohmeri
Meyerozyma guilliermondii